Resources

Proteomics Databases



Metabolomics Databases

• • Antibody Sequencing: How It Works and When to Use It

  Antibody projects often reach a point where binding data alone is not enough. A monoclonal antibody may show strong activity in ELISA or cell assays, yet the team may not know the exact heavy-chain and light-chain sequences. A legacy hybridoma may lose productivity. A purified antibody may come from an old inventory with incomplete records. In each case, the sequence becomes the bridge between a useful binder and a reproducible research or development asset.

• • Antibody Sequencing Cost Guide: What Drives Price and Turnaround

  Project cost is shaped by more than the number of samples. A simple hybridoma sequence recovery project and a difficult de novo sequencing project from limited purified protein require different levels of preparation, instrumentation, assembly, and review. The same keyword can describe very different scopes of work.

• • De Novo Sequencing Proteomics: When to Use It for Novel Peptides, Sequence Gaps, and Unexpected Variants

  Technical guide for De Novo Sequencing Proteomics: When to Use It for Novel Peptides, Sequence Gaps, and Unexpected Variants.

• • How to Scope a Peptide De Novo Sequencing Project: Sample Type, Spectral Readiness, and Deliverable Planning

  Technical guide for How to Scope a Peptide De Novo Sequencing Project: Sample Type, Spectral Readiness, and Deliverable Planning.

• • Whole Genome Sequencing De Novo Assembly: A Planning Guide for New Organism and Non-Reference Genome Projects

  Technical guide for Whole Genome Sequencing De Novo Assembly: A Planning Guide for New Organism and Non-Reference Genome Projects.

• • Why Peptide De Novo Sequencing Fails on Poor MS/MS Spectra and How to Improve Sequence Confidence

  Technical guide for Why Peptide De Novo Sequencing Fails on Poor MS/MS Spectra and How to Improve Sequence Confidence.

• • PEAKS De Novo Sequencing: When Software-Centered Analysis Is Enough and When Expert Review Still Matters

  Technical guide for PEAKS De Novo Sequencing: When Software-Centered Analysis Is Enough and When Expert Review Still Matters.

• • De Novo Peptide Sequencing by Deep Learning: What It Changes in Spectrum Interpretation and Confidence Assessment

  Technical guide for De Novo Peptide Sequencing by Deep Learning: What It Changes in Spectrum Interpretation and Confidence Assessment.

• • De Novo Sequencing Strategy: How to Choose Read Length, Platform Mix, and Assembly Path

  Technical guide for De Novo Sequencing Strategy: How to Choose Read Length, Platform Mix, and Assembly Path.

• • De Novo Plasmid Sequencing: When Partial Read Confirmation Is Not Enough for Construct Verification

  Technical guide for De Novo Plasmid Sequencing: When Partial Read Confirmation Is Not Enough for Construct Verification.